Introduction: CMS-2728 form (Medical Evidence Report) assesses 23 comorbidities chosen to reflect poor outcomes and increased mortality risk. Previous studies questioned the validity of physician reporting on forms CMS-2728. We hypothesize that reporting of comorbidities by computer algorithms identifies more comorbidities than physician completion, and, therefore, is more reflective of underlying disease burden. Methods: We collected data from CMS-2728 forms for all 296 patients who had incident ESRD diagnosis and received chronic dialysis from 2005 through 2014 at Indiana University outpatient dialysis centers. We analyzed patients' data from electronic medical records systems that collated information from multiple health care sources. Previously utilized algorithms or natural language processing was used to extract data on 10 comorbidities for a period of up to 10 years prior to ESRD incidence. These algorithms incorporate billing codes, prescriptions, and other relevant elements. We compared the presence or unchecked status of these comorbidities on the forms to the presence or absence according to the algorithms. Findings: Computer algorithms had higher reporting of comorbidities compared to forms completion by physicians. This remained true when decreasing data span to one year and using only a single health center source. The algorithms determination was well accepted by a physician panel. Importantly, algorithms use significantly increased the expected deaths and lowered the standardized mortality ratios. Discussion: Using computer algorithms showed superior identification of comorbidities for form CMS-2728 and altered standardized mortality ratios. Adapting similar algorithms in available EMR systems may offer more thorough evaluation of comorbidities and improve quality reporting.
INTRODUCTION
The United States congress legislated in 1972 the End Stage Renal Disease (ESRD) national program under Medicare. 1 Roughly 5.6% of all Medicare spending goes towards ESRD care. 2 However, patients with ESRD receiving Medicare benefits constitute only 1% of all Medicare beneficiaries. 3 Completion of Form CMS-2728 (End Stage Renal Disease Medical Evidence Report) for patients with a new diagnosis of ESRD is required. 4 The comorbidity section on the current version of the form contains 23 comorbid conditions that are chosen to reflect important conditions that are associated with mortality. The presence or absence of each of these weighted comorbidities is used to then calculate the comorbidity index [Supporting Information Table 1 ]. In turn, this index is used to calculate the expected death for the patient and the Standardized Mortality Ratio (SMR) for a facility level assessment of patients who receive renal replacement therapy at a given point in time. 5 SMR compares the mortality of a dialysis facility to what would be expected nationally given the same patient characteristics. The SMR is used for the public five star rating quality metric for dialysis facilities, 6 although at this time, it is not yet part of the Quality Incentive Program (QIP). 7 The law requires that the comorbidity section of the form needs to be completed by the nephrologist whereas other sections can be completed by support staff in the dialysis facility. Significant time, effort and extensive access to the medical record may be needed for physicians to accurately complete the 2728 form, and previous studies have confirmed that the current system of manual completion is often erroneous. [8] [9] [10] [11] [12] Data from the previous 10 years can be used for completion, but evaluating such voluminous data from multiple Electronic Medical Records (EMR) systems is time consuming. In this study, we hypothesized that computer algorithms would be superior to physician data extraction from EMR systems to determine the presence or absence of comorbidities in the 2728 form.
METHODS AND ANALYSIS

Data extraction
We collected all 2728 forms that reported a chronic dialysis start date between 1/1/2005 and 12/31/2014 at Indiana University Health (IU Health) outpatient dialysis facilities which provide treatment to patients under the care of IU Nephrology physicians group. Forms that were of older versions and those that contained significantly unreadable data were excluded (n 5 61). Forms were matched to their respective electronic charts across multiple health care institutions with different EMR systems which was facilitated by using the Indiana Health Information Exchange network. 13 This information exchange network allows standardized access to clinical data repositories from many health care centers operating different EMR systems in the Indianapolis metropolitan area.
A total of 296 unique electronic record-form pairs were available for analysis. The study was approved by the institutional review board. EMR data access permissions were granted by the relevant institutions participating in the health information exchange network.
Determination of comorbidities
The selection of comorbidities to target was based on the presence of an existing comorbidity defining computer algorithm. These algorithms were developed by Regenstrief Institute and used for quality assessment and research. We collaborated with Regenstrief Institute to implement these algorithms on the EMR data of our cohort. Multiple elements were included in the computer algorithms, including billing codes, diagnoses terms, medications, and laboratory data. Summary and detailed listings of all utilized elements are found in the supplement [ Table 2 and spreadsheet]; all of the components utilized are commonly available in commercial electronic medical record systems. Nine computer algorithms were run on each of the subjects' records to determine the status (present or absent) for of the following comorbidities: congestive heart failure (CHF), diabetes mellitus (DM), hypertension (HTN), coronary artery disease (CAD), chronic obstructive pulmonary disease (COPD), alcohol abuse, malignancy, illicit drug use, and cerebrovascular accident (CVA). These algorithms have been previously used in research publications. [14] [15] [16] [17] In addition to the nine previously utilized computer algorithms, we also tested the ability of natural language processing (NLP) to capture wheelchair use, as a surrogate for inability to ambulate which is heavily weighted in the SMR calculations. 18 We examined medical records from the 2 years prior to the onset of ESRD. Natural language processing is a technique in which raw medical text reports can be parsed into structured data for systematic analysis. 19 We then applied a five-level Likert scale to determine likelihood of wheelchair dependence. We considered patients with intermediate to high level to have inability to ambulate.
Calculation of SMR
Technical spreadsheets were obtained from the Kidney Epidemiology and Cost Center (KECC) to calculate the comorbidity index, expected deaths, and the SMR such that the years of data collection reflected the SMR calculations used that year. 20 The KECC conducts epidemiologic, policy, and outcomes research related to CKD and ESRD and is funded by CMS and other government and private funding sources. 21 We calculated a composite SMR by pooling patients in our cohort as if they are in one presumed dialysis facility. There is a distinct technical spreadsheet every year that has the model used that year built-in to perform the aforementioned key calculations. Interactive sheets prior to 2009 are not available; thus we only compared the SMR for 2009 through 2014. Days at risk were adjusted based on the technical sheets' supplementary instructions in order to mimic the calculations performed by the KECC. These adjustments included the exclusion of the first 90 days of initiating first chronic renal replacement therapy, assignment to each dialysis unit starting at day 61 of receiving chronic dialysis therapy at that unit. As noted by the technical notes on the SMR calculation sheets, The SMR calculation using the technical spreadsheets may differ from the published SMR. This difference is attributed to additional adjustments made to calculate the days at risk, and capturing of death events for up to 60 days after a transfer out of a facility. We used the web-based data collection system (CROWNWeb) to retrieve the chronological history of ESRD care which included information on date of onset of ESRD for native and transplanted kidneys, renal replacement time points for each dialysis facility.
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SMR calculation requires entry of patients' characteristics, days at risk and comorbidities. We are comparing only the difference in SMR between the forms and computer algorithm based on differences in comorbidities capture. Patients' characteristics and days at risk were similar when entered for calculation for both the forms and computer algorithms. The only data not used in the SMR calculation was BMI due to being near uniformly missing on the forms. This is to ensure that any difference in the calculated SMR is due only to the differences in comorbidities identification between the two methods.
Physician acceptance of algorithms
We randomly sampled 15 patients for each comorbidity where there was a discrepant result indicating presence by computer algorithm and absence (or not checked) by physician. Because form 2728 instructions do not provide a clear defining period for alcohol abuse, we empirically defined it as alcohol abuse within one year prior to ESRD incidence for which there were eight patients. The clinical elements of the EMR that were used by the computer algorithm were retrieved and assessed by a panel of four nephrologists. Those elements were felt to be reasonable and accurate to decide comorbidity status; those patients in which two of the four physicians felt that the data extracted were insufficient to make a diagnosis were considered negative adjudication.
Statistical analysis
We used SAS software version 9.4 to perform the study analyses. Unless otherwise stated, we used an alpha of 0.05 as the cut off for statistical significance. We compared the presence of comorbidities, and SMR, between the forms (physician filled) and the output of the computer algorithms using McNemar test and Student's t test, respectively.
RESULTS
Comparison of comorbidities between forms and computer algorithms
There was a statistically significant increase in identification of comorbidities using the computer algorithms and natural language processing compared to comorbidities identification by the forms. This was true for all of the 10 comorbidities that were tested. [ Table 1] Additional comparisons were performed to determine if the superiority of computer algorithm in identifying comorbidities is due to more expanded data span (years) and data scope (EMR sources). As data span or scope was reduced, there was less disagreement between computer and physician. [ Table 2 ] demonstrates the "worse case" scenario with one year of data and only a local data source, and the number of significant disagreements remained for 4 out of 10 chosen comorbidities.
Standardized mortality ratio
The calculated SMR using the comorbidities identified by the computer algorithms was lower than the SMR calculated using the forms [ Table 3 ]. This was true for SMR calculation for each year between 2009 and 2014.
Physician acceptance
The adjudication of the computer algorithm compared to clinical decision making is shown in [ Table 4 ]. Overall there was agreement in 80% of cases reviewed that the computer algorithm accurately reflected the presence of the comorbidity. The discrepant cases were predominately heart failure and COPD. Manual review of records found either no echocardiogram tests or echocardiograms with only mild subnormal structural abnormalities in the case of heart failure, or no pulmonary function tests in the case of COPD, which the physicians felt needed to confirm the diagnosis.
DISCUSSION
We demonstrated that computer algorithms are more likely to document existing comorbidities and that the use of such algorithms for just 10 of the 23 comorbidities significantly alters the SMR. Although the reporting of comorbid conditions on form CMS 2728 was previously evaluated, 23, 24 our study is the first, to our knowledge, to use computer algorithms to interpret clinical data within a large cross-platform health information exchange network in ESRD population. The role for the machine to interpret clinical data from the EMR, called "EMR-based phenotyping," has seen a robust evolution in recent years and been used in numerous studies. 25, 26 This is augmented by the use of natural language processing which adds extra capacity to analyze less structured data such as raw text reports. 27 Other studies have previously evaluated the accuracy of data on forms 2728, similarly finding incomplete data. For example, one study found that there was underreporting of nursing home utilization on form 2728. 28 Two other studies revealed discrepancy on erythropoietin use between forms 2728 and claims data. 8, 9 Furthermore, inaccuracies of reported pre-dialysis nephrology care, 10 vascular access, 11 and cause of ESRD for glomerular diseases were documented. 12 Based on more disagreements with the 10 years of city-wide extracted data compared to 1 year of local data, it is likely that manual extraction by physicians is most limited by access to relevant data. However, even limiting the data extraction to local EMR and 1 year of data was superior to manual extraction indicating the potential for generalizability in existing EMRs. The deviation in reporting on form 2728 is concerning as it affects the quality of the data collected by the USRDS and KECC. This data is widely used for publication of the Annual Data Reports by the USRDS, public policy and funding decisions, and by researchers conducting epidemiological studies. Furthermore, suboptimal data created by inconsistent comorbidity status identification may impact the prognostication of patients with ESRD. This could also lead erroneously to a higher SMR which reflects negatively on the published performance metrics of dialysis facilities.
Our results demonstrate that the use of algorithms for only 10 comorbidities from a total of 23 on form 2728 changes the SMR by 0.04 to 0.10 in our dialysis units (based on each year's actual mortality and SMR formula). The deviation of SMR from 1 indicates the variation in mortality compared to the national mortality. An SMR of 1.2, for example, means that the mortality in the facility is 20% higher than expected compared to other units in the nation. Similarly, an SMR of 0.7 means that the facility mortality is 30% lower than the national, all given the same patients characteristics. Patients who have few comorbidities are expected to have lower calculated expected death compared to those who have more comorbidities. Failure to adequately report comorbidities will misclassify highly morbid patients into lower morbidity status making the ESRD population appear "healthier" than it really is. This results in lower expected deaths and a higher SMR using the existing KECC model for dialysis in our units. Our study corrected this comorbidity misclassification error and yielded appropriately higher comorbidity classification that is closer to the true comorbidity state of patients. We would expect an even larger change in SMR if computer algorithms are developed and used for all 23 comorbidities. However, if every facility in the nation used computer algorithms for identifying comorbidities, it would all balance out since the overall national SMR still has to be 1.0 and no facility would gain an SMR advantage unless it was more seriously underreporting comorbidities than others. In other words, the change in SMR that we observed is a direct result of the improvement in reporting of underlying comorbidities in our units compared to other units. If such an approach were widely adopted it would at least assure all facilities receive the standardized ratios they deserve and that data collected for research purposes is accurate and complete. Also notably, the change in expected death and 73 (11) 100 (15) 53 (8) 47 (7) 87 (13) 88 (7) 80 (12) 100 (15) 100 (15) 80 (103) subsequently the SMR was observed using the SMR formula of the KECC model. Our study design does not examine the actual mortality risk but rather proposes an alternative comorbidity reporting method. Prediction of mortality requires examination of the KECC model itself to examine whether actual mortality matches the predicted one. Significant government resources are spent to continuously improve the management of the ESRD program. The overarching aim is to improve ESRD care, reduce morbidity and mortality of ESRD patients, and contain the cost of this expensive health program. This of course, is related to the accuracy of the information, much of which is based on the baseline comorbidities. Based on our study, the implementation of computer algorithms may provide more accurate analyses of comorbidities. Such algorithms have multiple advantages. They are more rapid than cumbersome manual chat review, reducing the need for time and effort by physicians. Such an approach also offers a standardized method to interpret the clinical data removing potential subjectivity in data reporting. Such an approach also offers the ability to update at regular time intervals which may be more reflective of health status than only using baseline comorbidities. While there are multiple EMRs utilized across the country, the market is dominated by a few companies. Importantly, as health systems merge, a consolidated EMR across multiple health care venues has become the norm, rather than the exception. Thus, implementing such algorithms offers a feasible approach to analyze records and obtain quality data.
There are several limitations to this study. First, our computer algorithms may not be generalizable across all EMR systems, and thus may need to be modified for the data available. However, the importance of developing common language and platforms is a recognized goal for all of health care. EMR-based phenotyping is known for its challenges that include cross-institutional variations in algorithms performance as well as the heterogeneity in methods of validation of algorithms. 29, 30 We used an expert panel of four nephrologists to review the EMR elements used by the computer algorithms to determine comorbidity status. Although manual review by experts is considered the gold standard for validation, there is currently no consensus in the medical informatics community on standard approaches for the design of expert review panels and the number of records to be reviewed. 29 Because of this lack of gold standard, we chose to examine nine available algorithms that have been used locally use for research and quality purposes by the Regenstrief Institute; 15, 31, 32 moving forward would require design and validation (through iterative expert manual review) of algorithms for all of the comorbidities across other ESRD cohorts. In addition to algorithms, implementation would also require the use of NLP as not all comorbidities are assessable by algorithms. We, thus, used natural language processing for wheelchair use, as a proxy for inability to ambulate. Further iterations of our NLP queries on other ESRD cohorts would be needed before it can be valid independent of manual review. This could serve in the future as an alternative or additional method to algorithms for other comorbidities as well.
Our initial assessment of physician acceptance was very positive, with the primary disagreement for the diagnosis of CHF and COPD. This is likely due to lack of generalizability of CHF and COPD algorithms developed for the general population to ESRD population. For CHF, this could be driven by an element of ambiguity of its diagnosis and classification in patients with ESRD who are prone to recurrent volume overload from their renal disease. 33 Notably, when we eliminated the effects of CHF and COPD on calculations, the SMR difference between the forms and algorithms remained statistically significant.
CONCLUSIONS
Our findings show superior identification of comorbidities by computer algorithms compared to reporting by physicians for completion of form 2728. This results in different SMR and other standardized measures that draw upon comorbidities in the 2728 form. This may have macro implications, such as the quality of USRDS data, research, resource allocation, and dialysis units' star rating, as well as micro implications, such as better medical record accuracy in dialysis units to target previously unknown comorbidities and improve patient-directed care if those comorbidities are successfully addressed. This study was meant to serve as a demonstration of the potential utility of widespread adoption of algorithms and NLP. Further studies would be required to develop algorithms and/or NLP approaches to all comorbidities and testing these in multiple EMR/clinical settings.
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